Michael Barbella, Managing Editor12.06.23
Biome Analytics has released to market the Biome Surveillance Manager, its advanced cardiac ultrasound management tool. The solution leverages advanced and proprietary machine learning methods that extend the value of the Biome Performance Network Platform by helping clients access underserved patients and grow their cardiovascular (CV) programs.
The Biome Surveillance Manager addresses the challenge of high turnover for sonographers, improves the quality of reporting, and enables clients to effortlessly track volume, manage admissions and length of stay, and increase referrals, according to the company.
Ensuring adherence to protocols and delivering high-quality results are crucial for the early detection of cardiac diseases, better patient outcomes, and lower costs. By leveraging Biome's vast library of quality and financial improvement measures, users of the Biome Performance Network can increase volume by identifying under-treated patients and ensure that patients receive the best care at the lowest cost.
Using unique benchmarks, Biome Surveillance Manager monitors previous study comparisons, calculated ejection fractions, and other critical metrics, helping operators improve their quality and reduce variation. Equally important, cardiovascular teams and health systems can manage disease progression, determine the optimum intervention time, and prioritize patients most in need. By streamlining patient management, the Surveillance Manager helps hospitals increase contribution margin and plays a vital role in reducing liability for individuals with valvular disease.
"Biome is dedicated to transforming healthcare through innovative technology solutions," said Matthew Esham, vice president of Analytics at Biome. "The release of Biome’s Surveillance Manager is a testament to our commitment to empowering healthcare providers with the advanced data and insight they need to serve more patients, provide better care, and achieve greater margin—capabilities that drive operational efficiency, improve quality outcomes and enhance patient care."
Biome's Surveillance Manager represents a significant milestone and provides Biome clients with the tools and insight they need to better serve their cardiovascular population, eliminate "leakage," and continuously improve their clinical and financial performance across the care continuum.
Biome Analytics is a technology firm specializing in clinical performance improvement. The company partners with enterprise heart centers and cardiovascular teams, providing them with proprietary machine learning, human-enabled technology, and a community-driven knowledge network. By leveraging data assets and engaging physicians, Biome Analytics accelerates performance improvement and enables its clients to achieve superior clinical and financial outcomes.
The Biome Surveillance Manager addresses the challenge of high turnover for sonographers, improves the quality of reporting, and enables clients to effortlessly track volume, manage admissions and length of stay, and increase referrals, according to the company.
Ensuring adherence to protocols and delivering high-quality results are crucial for the early detection of cardiac diseases, better patient outcomes, and lower costs. By leveraging Biome's vast library of quality and financial improvement measures, users of the Biome Performance Network can increase volume by identifying under-treated patients and ensure that patients receive the best care at the lowest cost.
Using unique benchmarks, Biome Surveillance Manager monitors previous study comparisons, calculated ejection fractions, and other critical metrics, helping operators improve their quality and reduce variation. Equally important, cardiovascular teams and health systems can manage disease progression, determine the optimum intervention time, and prioritize patients most in need. By streamlining patient management, the Surveillance Manager helps hospitals increase contribution margin and plays a vital role in reducing liability for individuals with valvular disease.
"Biome is dedicated to transforming healthcare through innovative technology solutions," said Matthew Esham, vice president of Analytics at Biome. "The release of Biome’s Surveillance Manager is a testament to our commitment to empowering healthcare providers with the advanced data and insight they need to serve more patients, provide better care, and achieve greater margin—capabilities that drive operational efficiency, improve quality outcomes and enhance patient care."
Biome's Surveillance Manager represents a significant milestone and provides Biome clients with the tools and insight they need to better serve their cardiovascular population, eliminate "leakage," and continuously improve their clinical and financial performance across the care continuum.
Biome Analytics is a technology firm specializing in clinical performance improvement. The company partners with enterprise heart centers and cardiovascular teams, providing them with proprietary machine learning, human-enabled technology, and a community-driven knowledge network. By leveraging data assets and engaging physicians, Biome Analytics accelerates performance improvement and enables its clients to achieve superior clinical and financial outcomes.